How AI Can Help Physicians Identify Eligible Trials Faster

In a recent video interview with Applied Clinical Trials, Adrianne Rivard, senior community development manager, myTomorrows, discussed the challenges physicians face in identifying clinical trials. Highlighting insights from a recent myTomorrows report on the need to streamline clinical operations, Rivard touched on the use of artificial intelligence (AI) to streamline pre-screening, which can reduce the need for multiple databases. She also discussed how AI tools are gaining use, necessitating compliance with data privacy standards and ongoing education to build trust among physicians.

Rivard: That's a great place to start. To give a bit of context, I'm on the medical community team at myTomorrows, which is a global health tech company that connects patients with pre-approval treatment options. Considering that there are 500,000 clinical trials registered globally, you can imagine that the pre-screening process for these patients, for these pre-approval options, is super time consuming. It's manual, it's complex, and this is putting a lot of burden on physicians. To better understand those challenges and to really dig in a little bit deeper, we surveyed 100 US-based physicians across many different specialties. One of the main takeaways was that we really need to reduce the amount of time and effort that physicians are spending and pre-screening patients and really trying to identify relevant options for their patients. I think one of the ways to do this is by adopting the use of AI, which is what we do at myTomorrows.